BARDA Technology Innovation to Combat Opioids

Raleigh, NC

The Biomedical Advanced Research and Development Authority (BARDA) is leading an interagency group to develop a wearable device to detect, and possibly treat, an opioid overdose.  This group, Technology Innovation to Combat Opioids (TICO) is holding a Deep Dive on Feb 12-13, 2019 to review possible technologies being developed in this area.  Specifically, we are looking for wearables or software as a medical device that are no larger than the palm of your hand and measure a physiological response indicative of an opioid overdose.  Examples of possible markers that could be incorporated into the device include, but are not limited to, respiratory rate, blood carbon dioxide or oxygen content, brain activity and opioid levels. The device should have the ability to alert potential caretakers nearby that the wearer is in distress and, potentially, have the capability to dispense a treatment for the overdose event.  The technologies should be at a maturity level capable of undergoing pivotal clinical trials in 2020.

 

TICO invites anyone with an innovative idea in this space to submit a 1-2 page summary of their device that addresses the following items:

1.      Provide a high-level device description including how the device detects possible opioid overdose.

2.      How does the device notify potential caretakers? Does it notify people nearby?  If so, how?

3.      Description of the user population and use environment?

4.      What are the performance limitations for the device?

5.      How does the device treat an opioid overdose if that is a feature?

6.      Do you own the intellectual property for this technology?

 

TICO will review each submission and invite selected participants to present their technology at the Deep Dive on Feb 12-13, 2019.  Travel funding is not available, however, this meeting will serve as market research for the solicitation that will be issued by BARDA to fund the clinical study.  Accommodations can also be made for a virtual presentation.  Submissions and questions can be sent to Kristen Herring Kristen.herring@hhs.gov and should be received no later than Jan. 22nd.

This resource is related to: